BRPI0809330B8 - uso de um ou mais oligômeros de ácido láctico, e, composição farmacêutica - Google Patents
uso de um ou mais oligômeros de ácido láctico, e, composição farmacêuticaInfo
- Publication number
- BRPI0809330B8 BRPI0809330B8 BRPI0809330A BRPI0809330A BRPI0809330B8 BR PI0809330 B8 BRPI0809330 B8 BR PI0809330B8 BR PI0809330 A BRPI0809330 A BR PI0809330A BR PI0809330 A BRPI0809330 A BR PI0809330A BR PI0809330 B8 BRPI0809330 B8 BR PI0809330B8
- Authority
- BR
- Brazil
- Prior art keywords
- lactic acid
- acid oligomers
- infection
- pharmaceutical composition
- hpv
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/34—Esters of acyclic saturated polycarboxylic acids having an esterified carboxyl group bound to an acyclic carbon atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gynecology & Obstetrics (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Endocrinology (AREA)
- Biotechnology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
uso de um ou mais oligômeros de ácido láctico, e, composição farmacêutica. uso de um ou mais oligômeros de ácido láctico com a seguinte fórmula (i) em que n é número inteiro de 2 a 25 tal como, por exemplo, de 2 a 20, de 3 a 25, de 3 a 25, de 3 a 20, de 2 a 15, de 3 a 15, de 2 a 10, de 3 a 10, de 4 a 10 ou um produto oligomérico de ácido láctico para a profilaxia e/ou tratamento de uma doença ou condição que se beneficia de um ambiente ácido especialmente um infecção ginecológica, tal como uma infecção bacteriana, tal como vaginose bacteriana, colpite não específica, colpite senil, cervicite e uretrite, uma infecção fúngica, tal como candidose (candida albicans ), criptococose , actinomicose ou uma infecção viral, tal como vírus da imunodeficiência humana (hpv), vírus do herpes simples (hsv), vírus de papiloma humana (hpv).
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200700508 | 2007-03-30 | ||
| DKPA200700508 | 2007-03-30 | ||
| PCT/EP2008/002505 WO2008119518A1 (en) | 2007-03-30 | 2008-03-28 | Use of oligomers of lactic acid in the treatment of gynaecological disorders |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BRPI0809330A2 BRPI0809330A2 (pt) | 2014-09-09 |
| BRPI0809330B1 BRPI0809330B1 (pt) | 2019-12-17 |
| BRPI0809330B8 true BRPI0809330B8 (pt) | 2021-05-25 |
Family
ID=39494560
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0809330A BRPI0809330B8 (pt) | 2007-03-30 | 2008-03-28 | uso de um ou mais oligômeros de ácido láctico, e, composição farmacêutica |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US8425894B2 (pt) |
| EP (2) | EP2142186B1 (pt) |
| JP (2) | JP5409596B2 (pt) |
| KR (1) | KR101518014B1 (pt) |
| CN (2) | CN101677980B (pt) |
| AU (1) | AU2008234064B2 (pt) |
| BR (1) | BRPI0809330B8 (pt) |
| CA (1) | CA2681803C (pt) |
| CY (1) | CY1115310T1 (pt) |
| DK (1) | DK2142186T3 (pt) |
| ES (1) | ES2482190T3 (pt) |
| HR (1) | HRP20140559T1 (pt) |
| MX (1) | MX2009010445A (pt) |
| PL (1) | PL2142186T3 (pt) |
| PT (1) | PT2142186E (pt) |
| RU (1) | RU2459620C2 (pt) |
| SI (1) | SI2142186T1 (pt) |
| WO (1) | WO2008119518A1 (pt) |
| ZA (1) | ZA200907215B (pt) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2009010445A (es) | 2007-03-30 | 2010-01-29 | Laccure Ab | Uso de oligomeros de acido lactico en el tratamiento de trastornos ginecologicos. |
| CN101797269B (zh) * | 2010-03-23 | 2012-01-04 | 杨霞 | 一种调节女性阴道微生态的生理平衡液 |
| RU2422147C1 (ru) * | 2010-03-29 | 2011-06-27 | Государственное образовательное учреждение высшего профессионального образования "Пермская государственная медицинская академия имени академика Е.А. Вагнера Федерального агентства по здравоохранению и социальному развитию" | Способ лечения неспецифического аэробного вагинита |
| US9155873B2 (en) | 2011-05-17 | 2015-10-13 | Reprotect, Inc. | Reusable intravaginal delivery device, system, and method |
| CN102274333A (zh) * | 2011-08-22 | 2011-12-14 | 谢英华 | 一种治疗阴道炎的外洗中药 |
| CN102579829B (zh) * | 2012-03-06 | 2013-09-18 | 康莉 | 一种治疗牛放线菌病的中药组合物及其制备方法 |
| CN110693812A (zh) | 2012-06-13 | 2020-01-17 | 伊沃菲姆股份有限公司 | 用于增强避孕杀微生物剂有效性的组合物和方法 |
| KR102089117B1 (ko) * | 2012-07-16 | 2020-04-16 | 라큐어 에이비 | 올리고머 락트산을 포함하는 약제학적 조성물 |
| CN102885850B (zh) * | 2012-10-15 | 2013-08-07 | 山东省医疗器械研究所 | 一种治疗阴道炎的多孔凝胶颗粒剂 |
| AU2014368971B2 (en) | 2013-12-19 | 2020-02-06 | Evofem, Inc. | Compositions and methods for inhibiting inflammation and diseases using an alginic acid-based antimicrobial compound |
| US9895311B2 (en) * | 2014-09-25 | 2018-02-20 | Pharmiva Ab | Foam-forming compositions and methods for delivering an active to a body cavity |
| CA3013809C (en) | 2016-04-06 | 2024-01-02 | Gedea Biotech Ab | Glucono delta-lactone for treatment of vaginal fungal infections |
| US10249017B2 (en) * | 2016-08-11 | 2019-04-02 | Intel Corporation | Apparatus and method for shared resource partitioning through credit management |
| WO2018049326A1 (en) * | 2016-09-12 | 2018-03-15 | Evofem Biosciences, Inc. | Combination gel for sexually transmitted infections |
| CN110225750A (zh) | 2016-10-04 | 2019-09-10 | 伊沃菲姆股份有限公司 | 细菌性阴道病的治疗和预防方法 |
| MX384337B (es) * | 2016-10-13 | 2025-03-14 | Catalent Uk Swindon Zydis Ltd | Composiciones farmacéuticas liofilizadas para suministro vaginal. |
| HUE064590T2 (hu) * | 2018-03-29 | 2024-03-28 | The Materia Company Ltd | Intravaginális készítmény |
| CN113423470B (zh) * | 2019-02-13 | 2024-07-09 | 三吉油脂株式会社 | 化妆品配合剂、化妆品及其制造方法 |
| US20250161348A1 (en) | 2022-03-01 | 2025-05-22 | Combe Incorporated | Process for preparation of compositions of oligomers of lactic acid |
| AU2023452829A1 (en) * | 2023-07-07 | 2026-02-19 | Changchun Sinobiomaterials Co., Ltd. | Muscle atrophy |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4431427A (en) * | 1981-10-05 | 1984-02-14 | University Of Delaware | Tampons and their manufacture |
| US5274127A (en) * | 1990-09-18 | 1993-12-28 | Biopak Technology, Ltd. | Lactide production from dehydration of aqueous lactic acid feed |
| JP2919912B2 (ja) | 1990-05-23 | 1999-07-19 | 鐘紡株式会社 | 修飾プロテアーゼ及びその製造法 |
| US5142023A (en) * | 1992-01-24 | 1992-08-25 | Cargill, Incorporated | Continuous process for manufacture of lactide polymers with controlled optical purity |
| JPH07132127A (ja) | 1993-06-17 | 1995-05-23 | Mitsui Toatsu Chem Inc | 生理用ナプキン |
| JPH07258526A (ja) | 1994-02-24 | 1995-10-09 | Ecological Chem Prod Co | 水分含有食品を包装するための組成物及び方法 |
| US5521278A (en) * | 1994-08-18 | 1996-05-28 | Ecological Chemical Products | Integrated process for the manufacture of lactide |
| JP2864218B2 (ja) | 1994-12-06 | 1999-03-03 | 株式会社日本製鋼所 | ポリ乳酸共重合体の製造方法 |
| US6369116B1 (en) * | 1995-06-02 | 2002-04-09 | Oculex Pharmaceuticals, Inc. | Composition and method for treating glaucoma |
| JPH09227388A (ja) * | 1996-02-15 | 1997-09-02 | Naganushi Tetsuaki | 大腸癌、食道癌及び乳癌より選ばれた癌に用いる抗悪性腫瘍剤 |
| AU2459497A (en) | 1996-05-31 | 1998-01-05 | Research And Development Institute, Inc. | Urinary medical devices |
| US6229046B1 (en) | 1997-10-14 | 2001-05-08 | Cargill, Incorported | Lactic acid processing methods arrangements and products |
| JP2000072680A (ja) * | 1998-08-25 | 2000-03-07 | Shiyumeidou:Kk | 免疫機能調節剤 |
| JP2001139476A (ja) * | 1999-11-15 | 2001-05-22 | Youichirou Naganushi | 癌を含めた悪性新生物に用いる抗悪性腫瘍剤 |
| RU2163810C1 (ru) * | 2000-05-18 | 2001-03-10 | Майорова Нина Федоровна | Состав для удаления доброкачественных новообразований на коже и слизистых и способ его получения |
| CA2434573A1 (en) * | 2001-01-12 | 2002-07-18 | Amato Pharmaceutical Products, Ltd. | Agent for protection against microorganism infection |
| EA200300828A1 (ru) | 2001-01-24 | 2003-12-25 | Амато Фармасьютикал Продактс, Лтд. | Средство против стресса |
| US20020177624A1 (en) * | 2001-03-16 | 2002-11-28 | Calvin Hanna | Acetate-lactate buffering vaginal gel and for method of making same and treating bacterial vaginosis |
| JP2002275256A (ja) * | 2001-03-19 | 2002-09-25 | Tendou Seiyaku Kk | 乳酸オリゴマーの製造方法 |
| AU2002325614A1 (en) | 2001-08-16 | 2003-03-03 | Pharmacon-Forschung Und Beratung Gmbh | Compounds containing lactic acid elements, method for the production and use thereof as pharmaceutically active substances |
| WO2003039560A1 (en) * | 2001-11-06 | 2003-05-15 | Amato Pharmaceutical Products, Ltd. | Antitumor agent containing lactic acid oligomer mixture |
| JP2004307561A (ja) * | 2003-04-02 | 2004-11-04 | Tendou Seiyaku Kk | 環状乳酸オリゴマーの製造方法 |
| US20080125488A1 (en) | 2003-05-01 | 2008-05-29 | Leverve Xavier M | Lactate Containing Pharmaceutical Composition and Uses Thereof |
| JP4316299B2 (ja) * | 2003-06-03 | 2009-08-19 | 学校法人東海大学 | 鎖状乳酸オリゴマー誘導体およびその製造方法 |
| JP2005126361A (ja) * | 2003-10-23 | 2005-05-19 | Tendou Seiyaku Kk | ポリ乳酸混合物を含むマトリックスメタロプロテアーゼ抑制剤 |
| CN1562049A (zh) * | 2004-04-02 | 2005-01-12 | 聂四平 | 低聚果糖在制备治疗及预防阴道炎药中的应用 |
| US20050271726A1 (en) * | 2004-06-02 | 2005-12-08 | Albert Crum | Immune enhancing compositions and methods of use thereof |
| SE528337C2 (sv) | 2004-06-23 | 2006-10-24 | Nestor Medical Ab | Sammansättning innefattande mjölksyra och laktoferrin, eller ett peptidfragment därav, och användning av denna sammansättning för behandling av tillstånd i urogenitalsystemet |
| JP2006232909A (ja) * | 2005-02-23 | 2006-09-07 | Tokai Univ | 環状オリゴ乳酸 |
| JP4431102B2 (ja) | 2005-11-11 | 2010-03-10 | キャタピラージャパン株式会社 | カウンタウエイト及びカウンタウエイトの製造方法並びに作業機械 |
| RU2308970C1 (ru) * | 2006-03-10 | 2007-10-27 | Автономная некоммерческая организация "Институт молекулярной диагностики" (АНО "ИнМоДи") | Антибактериальное средство для лечения внутриклеточных инфекций |
| JP2007258526A (ja) | 2006-03-24 | 2007-10-04 | Konica Minolta Holdings Inc | 有機エレクトロルミネッセンス素子、及び有機エレクトロルミネッセンスディスプレイ |
| JP2008157576A (ja) | 2006-12-26 | 2008-07-10 | Sharp Corp | 加湿機 |
| MX2009010445A (es) | 2007-03-30 | 2010-01-29 | Laccure Ab | Uso de oligomeros de acido lactico en el tratamiento de trastornos ginecologicos. |
-
2008
- 2008-03-28 MX MX2009010445A patent/MX2009010445A/es active IP Right Grant
- 2008-03-28 JP JP2010500144A patent/JP5409596B2/ja not_active Expired - Fee Related
- 2008-03-28 WO PCT/EP2008/002505 patent/WO2008119518A1/en not_active Ceased
- 2008-03-28 EP EP08734874.4A patent/EP2142186B1/en active Active
- 2008-03-28 ES ES08734874.4T patent/ES2482190T3/es active Active
- 2008-03-28 US US12/594,147 patent/US8425894B2/en active Active
- 2008-03-28 CN CN2008800161538A patent/CN101677980B/zh active Active
- 2008-03-28 CA CA2681803A patent/CA2681803C/en active Active
- 2008-03-28 SI SI200831231T patent/SI2142186T1/sl unknown
- 2008-03-28 BR BRPI0809330A patent/BRPI0809330B8/pt active IP Right Grant
- 2008-03-28 AU AU2008234064A patent/AU2008234064B2/en active Active
- 2008-03-28 PT PT87348744T patent/PT2142186E/pt unknown
- 2008-03-28 HR HRP20140559AT patent/HRP20140559T1/hr unknown
- 2008-03-28 PL PL08734874T patent/PL2142186T3/pl unknown
- 2008-03-28 KR KR1020097022696A patent/KR101518014B1/ko not_active Expired - Fee Related
- 2008-03-28 CN CN201310450505.3A patent/CN103830216B/zh active Active
- 2008-03-28 RU RU2009140141/15A patent/RU2459620C2/ru active
- 2008-03-28 DK DK08734874.4T patent/DK2142186T3/da active
- 2008-03-28 EP EP13183687.6A patent/EP2679222A1/en not_active Withdrawn
-
2009
- 2009-10-15 ZA ZA2009/07215A patent/ZA200907215B/en unknown
-
2013
- 2013-03-28 US US13/852,668 patent/US8912232B2/en active Active
- 2013-08-01 JP JP2013160602A patent/JP5793542B2/ja not_active Expired - Fee Related
-
2014
- 2014-06-20 US US14/311,200 patent/US9315444B2/en active Active
- 2014-06-26 CY CY20141100463T patent/CY1115310T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0809330B8 (pt) | uso de um ou mais oligômeros de ácido láctico, e, composição farmacêutica | |
| Krylova et al. | The comparative analysis of antiviral activity of native and modified fucoidans from brown algae Fucus evanescens in vitro and in vivo | |
| BRPI0705319A2 (pt) | processo para obtenção de um complexo solúvel de resveratrol e/ou seus derivados; complexo de resveratrol e/ou seus derivados; composição nutracêutica | |
| CL2008000863A1 (es) | Compuestos derivados de 9-pirimidin-4-il-1-oxa-3,9-diaza-espiro(5.5)undecan-2-ona; composicion farmaceutica que contiene a dichos compuestos; y su uso para tratar o prevenir la infeccion del virus vih, artritis reumatoide, asma, enfermedad pulmonar obstructiva congestiva y el rechazo de transplantes de organos solidos. | |
| CY1113949T1 (el) | Αντιιικη συνθεση, η οποια περιεχει εναν θειικο πολυσακχαριτη: ι-καρραγενανη | |
| BRPI1006266A2 (pt) | adsorvato, forma de dosagem, processo para a preparação de um adsorvato, processo para a preparação de uma forma de dosagem, uso de um adsorvato | |
| UY33600A (es) | Análogos de carba-nucleósidos 2` - flúor sustituidos para tratamiento antiviral y uso de los mismos en la preparación de medicamentos | |
| BR112015000615A2 (pt) | purinas macrocíclicas para o tratamento de infecções virais | |
| UY32673A (es) | Nuevas pirimidinas, composiciones farmaceuticas que las contienen, procedimientos de preparaciones y su aplicacion como medicamentos | |
| IL287381B2 (en) | Pharmaceutical preparations of human rpe cells and uses thereof | |
| CL2008001123A1 (es) | Compuestos derivados de acido lipoico; formulacion farmaceutica que lo comprende; y uso en el tratamiento del cancer. | |
| CO2021009396A2 (es) | Análogos de rifamicina y conjugados de fármaco-anticuerpo de los mismos | |
| BR112013015149A2 (pt) | composição para solubilização de um fluoropolímero, composição de fluoropolímero combinação de solventes, processos de preparação de uma composição, uso da composição de fluoropolímero, processo para revestimento de um substrato e uso da combinação de solventes | |
| AR063747A1 (es) | Definilazetidinona sustituida con acido piperazina-1-sulfonico y que tiene propiedades farmacologicas mejoradas | |
| CO2017000220A2 (es) | Moléculas que tienen cierta utilidad pesticida, intermedios, composiciones y procesos relacionados con las mismas | |
| ES2722436T3 (es) | Acidos hialurónicos sulfatados como agentes antivirales | |
| BR112015018491A2 (pt) | triterpenoides c-19-modificados com atividade inibidora de maturação de hiv | |
| AR088963A1 (es) | Complejo obtenido a partir de mezclas de acido hialuronico o una sal del mismo y sulfato de condroitina | |
| UY37086A (es) | Moléculas que tienen utilidad plaguicida y productos intermedios, composiciones y procesos, relacionados con las mismas | |
| BR112014013573A8 (pt) | materiais alcoxilados com baixo teor de bisfenol a residual, sua preparação e uso dos mesmos | |
| WO2008133759A3 (en) | Antiviral peptides | |
| BR112015022134A2 (pt) | composto, composição farmacêutica, adesivo, bastão, dispensador de spray, tubo ou caneta, e, método de tratamento de uma infecção | |
| BRPI0814725B8 (pt) | uso da composição antiviral | |
| ECSP088472A (es) | Derivados de 9-cloro-15-desoxiprostaglandina, procesos para su preparación y su uso como medicamento | |
| BR112019001207A2 (pt) | composição vaginal compreendendo uma combinação de estrogênio e vitamina d |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 17/12/2019, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 28/03/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |